PRESS RELEASE
News
-
-
PRESS RELEASE
Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline
Sanofi announces acquisition of Dynavax Technologies Corporation, expanding adult vaccine portfolio with hepatitis B and shingles candidates. Merger valued at $2.2 billion -
-
-
PRESS RELEASE
Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
Sanofi provides update on tolebrutinib regulatory submission for non-relapsing secondary progressive multiple sclerosis, with FDA issuing a complete response letter and further guidance expected in Q1 2026 -
PRESS RELEASE
Communiqué de presse : Sanofi fait le point sur la soumission réglementaire du tolebrutinib dans la sclérose en plaques secondaire progressive non-récurrente
Sanofi fait le point sur la soumission réglementaire du tolebrutinib dans la sclérose en plaques secondaire progressive non-récurrente. La FDA émet une lettre de réponse complète pour le tolebrutinib contre la SEPSPnr -
-
-
-
